The settlement will resolve allegations brought by 36 states against Medtronic. The states alleged Medtronic and its subsidiary Medtronic Minimed improperly solicited Medicaid recipients to use its insulin infusion pumps in violation of federal anti-solicitation rules.
As a result of the improper solicitation, Medtronic submitted fraudulent claims to the states’ Medicaid programs to receive reimbursement for the replacement insulin pumps, according to the report.
The lawsuit against Medtronic was filed in 2011 by a former Medtronic employee in the U.S. District Court for the Northern District of Texas.
More Articles on the False Claims Act:
5 Recent Employee Whistle-Blower Cases
Halifax Makes Final Attempt to Get Case Dismissed
False Claims Act Lawsuit Filed Against Continuum Health Partners
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
